Report Detail
COVID-19 Impact on Global Antihypertensive Drugs Market Insights, Forecast to 2026
- RnM3985349 |
- 03 June, 2020 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Antihypertensive drug is a kind of medicine that can control blood pressure and is used to treat hypertension.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antihypertensive Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Antihypertensive Drugs industry.
Based on our recent survey, we have several different scenarios about the Antihypertensive Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Antihypertensive Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antihypertensive Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antihypertensive Drugs market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Antihypertensive Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Antihypertensive Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Antihypertensive Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Antihypertensive Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antihypertensive Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antihypertensive Drugs market.
The following manufacturers are covered in this report:
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
Astra Zeneca
Daiichi Sankyo
Takeda
Actelion
United Therapeutics
Antihypertensive Drugs Breakdown Data by Type
Diuretic Antihypertensive
Sympathetic Suppressant
Renin-angiotensin System Inhibitor
Calcium Antagonist Medicine
vasodilator
Antihypertensive Drugs Breakdown Data by Application
The Old
Pregnant Woman
General Patient
1 Study Coverage
- 1.1 Antihypertensive Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Antihypertensive Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Antihypertensive Drugs Market Size Growth Rate by Type
- 1.4.2 Diuretic Antihypertensive
- 1.4.3 Sympathetic Suppressant
- 1.4.4 Renin-angiotensin System Inhibitor
- 1.4.5 Calcium Antagonist Medicine
- 1.4.6 vasodilator
- 1.5 Market by Application
- 1.5.1 Global Antihypertensive Drugs Market Size Growth Rate by Application
- 1.5.2 The Old
- 1.5.3 Pregnant Woman
- 1.5.4 General Patient
- 1.6 Coronavirus Disease 2019 (Covid-19): Antihypertensive Drugs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Antihypertensive Drugs Industry
- 1.6.1.1 Antihypertensive Drugs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Antihypertensive Drugs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Antihypertensive Drugs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Antihypertensive Drugs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Antihypertensive Drugs Market Size Estimates and Forecasts
- 2.1.1 Global Antihypertensive Drugs Revenue 2015-2026
- 2.1.2 Global Antihypertensive Drugs Sales 2015-2026
- 2.2 Antihypertensive Drugs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Antihypertensive Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Antihypertensive Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antihypertensive Drugs Competitor Landscape by Players
- 3.1 Antihypertensive Drugs Sales by Manufacturers
- 3.1.1 Antihypertensive Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Antihypertensive Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Antihypertensive Drugs Revenue by Manufacturers
- 3.2.1 Antihypertensive Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Antihypertensive Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Antihypertensive Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Antihypertensive Drugs Revenue in 2019
- 3.2.5 Global Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Antihypertensive Drugs Price by Manufacturers
- 3.4 Antihypertensive Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Antihypertensive Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antihypertensive Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Antihypertensive Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Antihypertensive Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Antihypertensive Drugs Sales by Type (2015-2020)
- 4.1.2 Global Antihypertensive Drugs Revenue by Type (2015-2020)
- 4.1.3 Antihypertensive Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Antihypertensive Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Antihypertensive Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Antihypertensive Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Antihypertensive Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Antihypertensive Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Antihypertensive Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Antihypertensive Drugs Sales by Application (2015-2020)
- 5.1.2 Global Antihypertensive Drugs Revenue by Application (2015-2020)
- 5.1.3 Antihypertensive Drugs Price by Application (2015-2020)
- 5.2 Antihypertensive Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Antihypertensive Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Antihypertensive Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Antihypertensive Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Antihypertensive Drugs by Country
- 6.1.1 North America Antihypertensive Drugs Sales by Country
- 6.1.2 North America Antihypertensive Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Antihypertensive Drugs Market Facts & Figures by Type
- 6.3 North America Antihypertensive Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Antihypertensive Drugs by Country
- 7.1.1 Europe Antihypertensive Drugs Sales by Country
- 7.1.2 Europe Antihypertensive Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antihypertensive Drugs Market Facts & Figures by Type
- 7.3 Europe Antihypertensive Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Antihypertensive Drugs by Region
- 8.1.1 Asia Pacific Antihypertensive Drugs Sales by Region
- 8.1.2 Asia Pacific Antihypertensive Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Antihypertensive Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Antihypertensive Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Antihypertensive Drugs by Country
- 9.1.1 Latin America Antihypertensive Drugs Sales by Country
- 9.1.2 Latin America Antihypertensive Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Antihypertensive Drugs Market Facts & Figures by Type
- 9.3 Central & South America Antihypertensive Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Antihypertensive Drugs by Country
- 10.1.1 Middle East and Africa Antihypertensive Drugs Sales by Country
- 10.1.2 Middle East and Africa Antihypertensive Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Antihypertensive Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Antihypertensive Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description, Business Overview and Total Revenue
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Antihypertensive Drugs Products Offered
- 11.1.5 Novartis Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Corporation Information
- 11.2.2 Pfizer Description, Business Overview and Total Revenue
- 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Pfizer Antihypertensive Drugs Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Johnson & Johnson
- 11.3.1 Johnson & Johnson Corporation Information
- 11.3.2 Johnson & Johnson Description, Business Overview and Total Revenue
- 11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Johnson & Johnson Antihypertensive Drugs Products Offered
- 11.3.5 Johnson & Johnson Recent Development
- 11.4 Sanofi
- 11.4.1 Sanofi Corporation Information
- 11.4.2 Sanofi Description, Business Overview and Total Revenue
- 11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Sanofi Antihypertensive Drugs Products Offered
- 11.4.5 Sanofi Recent Development
- 11.5 Lupin
- 11.5.1 Lupin Corporation Information
- 11.5.2 Lupin Description, Business Overview and Total Revenue
- 11.5.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Lupin Antihypertensive Drugs Products Offered
- 11.5.5 Lupin Recent Development
- 11.6 Ranbaxy Laboratories
- 11.6.1 Ranbaxy Laboratories Corporation Information
- 11.6.2 Ranbaxy Laboratories Description, Business Overview and Total Revenue
- 11.6.3 Ranbaxy Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Ranbaxy Laboratories Antihypertensive Drugs Products Offered
- 11.6.5 Ranbaxy Laboratories Recent Development
- 11.7 Merck
- 11.7.1 Merck Corporation Information
- 11.7.2 Merck Description, Business Overview and Total Revenue
- 11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Merck Antihypertensive Drugs Products Offered
- 11.7.5 Merck Recent Development
- 11.8 Astra Zeneca
- 11.8.1 Astra Zeneca Corporation Information
- 11.8.2 Astra Zeneca Description, Business Overview and Total Revenue
- 11.8.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Astra Zeneca Antihypertensive Drugs Products Offered
- 11.8.5 Astra Zeneca Recent Development
- 11.9 Daiichi Sankyo
- 11.9.1 Daiichi Sankyo Corporation Information
- 11.9.2 Daiichi Sankyo Description, Business Overview and Total Revenue
- 11.9.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Daiichi Sankyo Antihypertensive Drugs Products Offered
- 11.9.5 Daiichi Sankyo Recent Development
- 11.10 Takeda
- 11.10.1 Takeda Corporation Information
- 11.10.2 Takeda Description, Business Overview and Total Revenue
- 11.10.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Takeda Antihypertensive Drugs Products Offered
- 11.10.5 Takeda Recent Development
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description, Business Overview and Total Revenue
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Antihypertensive Drugs Products Offered
- 11.1.5 Novartis Recent Development
- 11.12 United Therapeutics
- 11.12.1 United Therapeutics Corporation Information
- 11.12.2 United Therapeutics Description, Business Overview and Total Revenue
- 11.12.3 United Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 United Therapeutics Products Offered
- 11.12.5 United Therapeutics Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Antihypertensive Drugs Market Estimates and Projections by Region
- 12.1.1 Global Antihypertensive Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Antihypertensive Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Antihypertensive Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Antihypertensive Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Antihypertensive Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Antihypertensive Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Antihypertensive Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Antihypertensive Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Antihypertensive Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Antihypertensive Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Antihypertensive Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Antihypertensive Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Antihypertensive Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Antihypertensive Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Antihypertensive Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Antihypertensive Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Antihypertensive Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Antihypertensive Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Antihypertensive Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Antihypertensive Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Antihypertensive Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Antihypertensive Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Antihypertensive Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antihypertensive Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Antihypertensive Drugs. Industry analysis & Market Report on COVID-19 Impact on Global Antihypertensive Drugs is a syndicated market report, published as COVID-19 Impact on Global Antihypertensive Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Antihypertensive Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
